Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

NCT00866918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

106

Enrollment

NETWORK

Sponsor class

Conditions

Childhood Acute Promyelocytic Leukemia With PML-RARA
Myeloid Neoplasm

Interventions

DRUG: Arsenic Trioxide
DRUG: Cytarabine
OTHER: Diagnostic Laboratory Biomarker Analysis
DRUG: Idarubicin
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Mitoxantrone Hydrochloride
DRUG: Tretinoin

Sponsor

Children's Oncology Group

Collaborators

[object Object]